| 摘要 |
Pyrrolo[3,4-c]pyrazole derivatives of formula (I) and pharmaceutically acceptable salts (hereof, as defined in the specification, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention can be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer. |
